Extranodal natural-killer/T-cell lymphoma, nasal type

Advances in Hematology

Volumn 2010, Issue , 2010, Pages

  Gill, Harinder ^a   Liang, Raymond H S ^a   Tse, Eric ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CD3 ANTIGEN; CD3 EPSILON; CD56 ANTIGEN; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; CANCER CHEMOTHERAPY; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER STAGING; EPSTEIN BARR VIRUS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOPATHOLOGY; HUMAN; IMMUNOPHENOTYPING; NK T CELL LYMPHOMA; PRIORITY JOURNAL; REVIEW; VIRUS INFECTION;

EID: 79952226950     PISSN: 16879104     EISSN: 16879112     Source Type: Journal    
DOI: 10.1155/2010/627401     Document Type: Review

References (32)

1. Spits H., Lanier L. L., Phillips J. H., Development of human T and natural killer cells Blood 1995 85 10 2654 2670
2. Chan J. K. C., Quintanilla-Martinez L., Ferry J. A., Peh S. C., Extranodal NK/Tcell lymphoma, nasal type WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues 2008 Lyon, France International Agency for Research on Cancer 285 288
3. Chan J. K. C., Jaffe E. S., Ralfkiaer E., Ko Y. H., Aggressive NKcell leukaemia WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues 2008 Lyon, France International Agency for Research on Cancer 276 277
4. Medeiros L. J., Peiper S. C., Elwood L., Yano T., Raffeld M., Jaffe E. S., Angiocentric immunoproliferative lesions: a molecular analysis of eight cases Human Pathology 1991 22 11 1150 1157
5. Ho F. C. S., Srivastava G., Loke S. L., Fu K. H., Leung B. P. Y., Liang R., Choy D., Presence of Epstein-Barr virus DNA in nasal lymphomas of B and 'T' cell type Hematological Oncology 1990 8 5 271 281
6. Gelb A. B., van de Rijn M., Regula D. P. Jr., EpteinBarr virusassociated na (Pubitemid 24292415)
7. Quintanilla-Martinez L., Kremer M., Keller G., Nathrath M., Gamboa-Dominguez A., Meneses A., Luna-Contreras L., Cabras A., Hoefler H., Mohar A., Fend F., p53 mutations in nasal natural killer/T-cell lymphoma from mexico: association with large cell morphology and advanced disease American Journal of Pathology 2001 159 6 2095 2105 (Pubitemid 33104264)
8. Au W. Y., Ma S. Y., Chim C. S., Choy C., Loong F., Lie A. K. W., Lam C. C. K., Leung A. Y. H., Tse E., Yau C. C., Liang R., Kwong Y. L., Clinicopathologic features and treatment outcome of mature T-cell and natural killer-cell lymphomas diagnosed according to the World Health Organization classification scheme: a single center experience of 10 years Annals of Oncology 2005 16 2 206 214 (Pubitemid 40309297)
9. Armitage J. O., A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma Blood 1997 89 11 3909 3918 (Pubitemid 27220933)
10. Hasserjian R. P., Harris N. L., NK-cell lymphomas and leukemias: a spectrum of tumors with variable manifestations and immunophenotype American Journal of Clinical Pathology 2007 127 6 860 868
11. Ando J., Sugimoto K., Ando M., Isobe Y., Sasaki M., Oshimi K., CD20-positive extranodal NK-cell lymphoma, nasal-type European Journal of Haematology 2008 80 6 549 550 (Pubitemid 351677460)
12. Gill H. S., Lau W.-H., Chan A. C.L., Leung R. Y.Y., Khong P.-L., Leung A. Y.H., Kwong Y.-L., CD20 expression in natural killer T cell lymphoma Histopathology 2010 57 1 147 167
13. Kwong Y. L., Natural killer-cell malignancies: diagnosis and treatment Leukemia 2005 19 12 2186 2194
14. Liang R., Advances in the management and monitoring of extranodal NK/T-cell lymphoma, nasal type British Journal of Haematology 2009 147 1 13 21
15. Robbins K. T., Fuller L. M., Osborne B., Primary lymphomas of the nasal cavity and paranasal sinuses Cancer 1985 56 4 814 819 (Pubitemid 15228274)
16. Ooi G. C., Chim C. S., Liang R., Tsang K. W. T., Kwong Y. L., Original report. Nasal T-cell/natural killer cell lymphoma: CT and MR imaging features of a new clinicopathologic entity American Journal of Roentgenology 2000 174 4 1141 1145 (Pubitemid 30180020)
17. Khong P. L., Pang C. B. Y., Liang R., Kwong Y. L., Au W. Y., Fluorine-18 fluorodeoxyglucose positron emission tomography in mature T-cell and natural killer cell malignancies Annals of Hematology 2008 87 8 613 621
18. Chan W. K.S., Au W.-Y., Wong C.-Y.O., Liang R., Leung A. Y.H., Kwong Y.-L., Khong P.-L., Metabolic activity measured by F-18 FDG PET in natural killer-cell lymphoma compared to aggressive B-and T-cell lymphomas Clinical Nuclear Medicine 2010 35 8 571 575
19. Chan K. C. A., Zhang J., Chan A. T. C., Lei K. I. K., Leung S. F., Chan L. Y. S., Chow K. C. K., Lo Y. M. D., Molecular characterization of circulating EBV DNA in the plasma of nasopharyngeal carcinoma and lymphoma patients Cancer Research 2003 63 9 2028 2032 (Pubitemid 36538602)
20. Au W. Y., Pang A., Choy C., Chim C. S., Kwong Y. L., Quantification of circulating Epstein-Barr virus (EBV) DNA in the diagnosis and monitoring of natural killer cell and EBV-positive lymphomas in immunocompetent patients Blood 2004 104 1 243 249 (Pubitemid 38879864)
21. Suzuki R., Suzumiya J., Yamaguchi M., Nakamura S., Kameoka J., Kojima H., Abe M., Kinoshita T., Yoshino T., Iwatsuki K., Kagami Y., Tsuzuki T., Kurokawa M., Ito K., Kawa K., Oshimi K., Prognostic factors for mature natural killer (NK) cell neoplasms: aggressive NK cell leukemia and extranodal NK cell lymphoma, nasal type Annals of Oncology 2009 21 5 1032 1040
22. Lee J., Suh C., Yeon H. P., Ko Y. H., Soo M. B., Jae H. L., Dae HO. L., Huh J., Sung Y. O., Kwon H. C., Hyo J. K., Soon IL. L., Jung H. K., Park J., Seok J. O., Kim K., Jung C., Park K., Won S. K., Extranodal natural killer T-cell lymphoma, nasal-type: a prognostic model from a retrospective multicenter study Journal of Clinical Oncology 2006 24 4 612 618 (Pubitemid 46630424)
23. Cheung M. M. C., Chan J. K. C., Lau W. H., Ngan R. K. C., Foo W. W. L., Early stage nasal NK/T-cell lymphoma: clinical outcome, prognostic factors, and the effect of treatment modality International Journal of Radiation Oncology Biology Physics 2002 54 1 182 190
24. Au W. Y., Kim S. J., Yiu H. H. Y., Ngan R. K. C., Loong F., Kim W. S., Kwong Y. L., Clinicopathological features and outcome of late relapses of natural killer cell lymphomas 10-29 years after initial remission American Journal of Hematology 2010 85 5 362 363
25. Yamaguchi M., Kita K., Miwa H., Nishii K., Oka K., Ohno T., Shirakawa S., Fukumoto M., Frequent expression of P-glycoprotein/MDR1 by nasal T-cell lymphoma cells Cancer 1995 76 11 2351 2356
26. Yamaguchi M., Tobinai K., Oguchi M., Ishizuka N., Kobayashi Y., Isobe Y., Ishizawa K., Maseki N., Itoh K., Usui N., Wasada I., Kinoshita T., Ohshima K., Matsuno Y., Terauchi T., Nawano S., Ishikura S., Kagami Y., Hotta T., Oshimi K., Phase I/II study of concurrent chemoradiotherapy for localized nasal natural killer/T-cell lymphoma: Japan clinical oncology group study JCOG0211 Journal of Clinical Oncology 2009 27 33 5594 5600
27. Kim S. J., Kim K., Kim B. S., Kim C. Y., Suh C., Huh J., Lee S. W., Kim J. S., Cho J., Lee G. W., Kang KI. M., Eom H. S., Pyo H. R., Ahn Y. C., Ko Y. H., Kim W. S., Phase II trial of concurrent radiation and weekly cisplatin followed by VIPD chemotherapy in newly diagnosed, stage IE to IIE, nasal, extranodal NK/T-cell lymphoma: consortium for improving survival of lymphoma study Journal of Clinical Oncology 2009 27 35 6027 6032
28. Yong W., Zheng W., Zhu J., Zhang Y., Wang X., Xie Y., Lin N., Xu BO., Lu A., Li J., L-asparaginase in the treatment of refractory and relapsed extranodal NK/ T-cell lymphoma, nasal type Annals of Hematology 2009 88 7 647 652
29. Yamaguchi M., Suzuki R., Kwong Y. L., Kim W. S., Hasegawa Y., Izutsu K., Suzumiya J., Okamura T., Nakamura S., Kawa K., Oshimi K., Phase I study of dexamethasone, methotrexate, ifosfamide, l-asparaginase, and etoposide (SMILE) chemotherapy for advanced-stage, relapsed or refractory extranodal natural killer (NK)/T-cell lymphoma and leukemia Cancer Science 2008 99 5 1016 1020 (Pubitemid 351997606)
30. Kwong Y. L., High-dose chemotherapy and hematopoietic SCT in the management of natural killer-cell malignancies Bone Marrow Transplantation 2009 44 11 709 714
31. Lee J., Au W. Y., Park M. J., Suzumiya J., Nakamura S., Kameoka J. I., Sakai C., Oshimi K., Kwong Y. L., Liang R., Yiu H., Wong K. H., Cheng H. C., Ryoo B. Y., Suh C., Ko Y. H., Kim K., Lee J. W., Kim W. S., Suzuki R., Autologous hematopoietic stem cell transplantation in extranodal natural killer/ T cell lymphoma: a multinational, multicenter, matched controlled study Biology of Blood and Marrow Transplantation 2008 14 12 1356 1364
32. Yokoyama H., Yamamoto J., Tohmiya Y., Yamada M. F., Ohguchi H., Ohnishi Y., Okitsu Y., Fukuhara N., Ohba-Ohtsuka R., Kohata K., Ishizawa K., Kameoka J., Harigae H., Allogeneic hematopoietic stem cell transplant following chemotherapy containing l-asparaginase as a promising treatment for patients with relapsed or refractory extranodal natural killer/T cell lymphoma, nasal type Leukemia and Lymphoma 2010 51 8 1509 151